Journal of Applied Physiology Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 104: 1006-1013, 2008. First published January 24, 2008; doi:10.1152/japplphysiol.01210.2007
8750-7587/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
104/4/1006    most recent
01210.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Craenenbroeck, E. M. F.
Right arrow Articles by Conraads, V. M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Craenenbroeck, E. M. F.
Right arrow Articles by Conraads, V. M. A.

A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile

Emeline M. F. Van Craenenbroeck,1,2 Christiaan J. Vrints,1,2 Steven E. Haine,1 Katrien Vermeulen,3 Inge Goovaerts,1 Viggo F. I. Van Tendeloo,2,3 Vicky Y. Hoymans,1,2 and Viviane M. A. Conraads1,2

1Department of Cardiology and 2Center for Cellular Therapy and Regenerative Medicine (CCRG), Antwerp University Hospital; and 3Vaccine and Infectious Disease Institute (VIDI), Laboratory for Experimental Hematology, University of Antwerp, Antwerp, Belgium

Submitted 13 November 2007 ; accepted in final form 24 January 2008


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Mobilization of bone marrow-derived endothelial progenitor cells (EPC) might explain exercise-induced improvement of endothelial function. We assessed whether a maximal exercise bout could alter the number of circulating EPC in healthy subjects and whether this effect is related to their cardiovascular risk profile. Additionally, we investigated possible mediators of this effect, namely nitric oxide (NO) bioavailability and vascular endothelial growth factor (VEGF) release. Healthy subjects (group 1, n = 11; group 2, n = 14) performed a symptom-limited cardiopulmonary exercise test on a bicycle ergometer. Numbers of CD34+/kinase insert domain receptor (KDR)+ cells were determined by flow-cytometric analysis, either after magnetic separation of CD34+ cells (group 1) or starting from whole blood (group 2). Serum concentrations of VEGF and NO metabolites were measured by using ELISA. Following exercise, EPC increased by 76% (15.4 ± 10.7 cells/ml vs. 27.2 ± 13.7 cells/ml; P = 0.01) in group 1 and by 69% in group 2 (30.9 ± 14.6 cells/ml vs. 52.5 ± 42.6 cells/ml; P = 0.03). The increase in EPC correlated positively with LDL and total cholesterol/HDL ratio and negatively with peak oxygen consumption and oxygen consumption at anaerobic threshold. VEGF levels increased with exercise, with a strong trend toward significance (P = 0.055). NO levels remained unchanged. The present study demonstrates that a maximal bout of exercise induces a significant shift in CD34+ cells toward CD34+/KDR+ cells. This response was larger in subjects with a less favorable lipid profile.

acute exercise; endothelial function


THE ENDOTHELIUM HAS EMERGED as the key regulator of vascular function. Disturbances in endothelial function precede the development of atherosclerotic lesions and accelerate the occurrence of clinical complications (7). Accumulating evidence indicates that circulating endothelial progenitor cells (EPC) play an important role in the maintenance and repair of the endothelium. These cells are recruited from the bone marrow, circulate in the peripheral blood, and have the capacity to differentiate into mature endothelial cells (39). In patients at cardiovascular risk (40), in those with coronary artery disease (30), and in chronic heart failure patients (35), the number of EPC is reduced. In addition to this quantitative deficit, subnormal function of EPC correlates with impaired endothelial function (14, 41). Conversely, interventions that improve endothelial function, such as physical exercise and statins, apparently have a potent EPC-mobilizing effect and increase their angiogenetic capacity (21, 36). Regular physical activity is a central component in the primary and secondary prevention of cardiovascular disease and is associated with reduced morbidity and improved cardiovascular prognosis (24). The benefits of moderate physical activity in both healthy and cardiovascular patients include improved peripheral and coronary endothelial function (6, 13) and collateralization in ischemic heart failure patients (4) and patients with peripheral artery occlusive disease (PAOD) (32).

However, the molecular mechanisms responsible for the beneficial effects of exercise are incompletely understood. The role of endothelial nitric oxide synthase (eNOS) upregulation induced by shear stress, resulting in improved endothelial-dependent vasodilation, has been held largely responsible for the exercise-induced benefits. In addition, the role of nitric oxide (NO) as an EPC-mobilizing factor is being progressively disclosed. In an animal model (22), eNOS dependency of exercise-induced EPC mobilization and improved neoangiogenesis were clearly shown.

The aim of the present study was to assess whether a single bout of exercise can alter the number of circulating EPC in the absence of vascular disease and whether this effect is related to the subject's lipid profile. Additionally, we looked further into possible mediators of this effect, namely NO bioavailability and the release of VEGF.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Subjects

Inclusion criteria for enrolment in this study were nonsmoking, no significant medical history, no active disease nor pharmacological treatment, and no known cardiovascular risk factors. Enrolment took place in May 2005 (group 1, subjects aged between 20 and 30 years; n = 11) and in January 2007 (group 2, subjects aged between 20 and 50 years; n = 14). The study was approved by the local ethical committee, and written informed consent was obtained from all participants.

Study Design

Subjects were asked to refrain from caffeine-containing beverages and excessive physical exertion for 24 h before the study. After an overnight fast, they were called in for a symptom-limited cardiopulmonary exercise test on a graded bicycle ergometer. Immediately before and 10 min after peak exercise, venous blood samples were drawn from an antecubital vein. The first 3 ml of blood were discarded to prevent contamination with circulating endothelial cells (11).

Cardiopulmonary Exercise Test

Subjects started exercising at a load of 40 Watts, with an incremental load of 20 Watts every minute. Twelve-lead ECG and heart rate were recorded continuously, and automatic cuff blood pressure was measured every 2 min and at peak exercise. Breath-by-breath gas-exchange measurements were performed by using a metabolic cart. Ventilation (V), oxygen uptake (VO2), and carbon dioxide production (VCO2) were determined online every 15 s. Peak oxygen consumption (VO2peak) was determined as the highest attained VO2 during the final 30 s of exercise and was also expressed as a percentage of the predicted value (VO2peak%). Subjects were encouraged to exercise until exhaustion, and all of them performed a maximal test according to the identification of the anaerobic threshold (V-slope method) (2).

Laboratory Measurements

Flow-cytometric analysis of progenitor cells.   Fasting venous blood was collected in acid citrate dextrose tubes and was processed within 4 h of collection. FITC-labeled anti-CD34 and peridinin-chlorophyll protein complex (PerCP)-labeled anti-CD3 were obtained from BD Pharmingen; phycoerythrin (PE)-labeled anti-kinase insert domain receptor (KDR) was from R&D Systems, and incubation was performed following the manufacturer's instructions. DRAQ5 (Biostatus) was used as a nuclear stain. All samples were pretreated with Fc receptor-blocking reagent (Miltenyi Biotec) for 15 min at room temperature to prevent nonspecific binding of antibodies.

The gating strategy for group 1 samples was as follows (Fig. 1) : peripheral blood mononuclear cells (PBMC) were isolated by density-gradient centrifugation from 40 ml of blood with Lymphosep (MP Biomedicals), and subsequently, CD34+ cells were immunomagnetically separated by using a MiniMacs CD34 separation kit (Miltenyi Biotec). Purity levels ranged from 33.3 to 65%. These CD34+ cells were analyzed for the coexpression of KDR after exclusion of cell aggregates and nonnucleated cells. For the calculation of the absolute number of CD34+/KDR+ cells per milliliter of blood, the content of CD34+ cells in whole, peripheral blood was analyzed by using anti-CD34-FITC antibody. Starting from this number, the absolute number of CD34+/KDR+ cells could be deducted, thereby taking the purity levels of CD34 isolation into account.


Figure 1
View larger version (42K):
[in this window]
[in a new window]

 
Fig. 1. Gating strategy for group 1 CD34-enriched samples. Firstly, the mononuclear cells are gated in a forward scatter (FS)/side scatter (SS) plot (A). Single cells are selected on a FS area/FS peak plot (B) and nucleated cells by using DRAQ5 (C). Cells positive for CD34 with low side scatter are included (D) and a scatter back-gating is performed that allows exclusion of spurious events (E). Cells double positive for CD34 and kinase insert domain-containing receptor (KDR) expression are analyzed in this cluster (F).

 
For the analysis of the samples of group 2 (Fig. 2), 200 µl of whole blood was incubated with anti-KDR-PE and anti-CD34-FITC. After lysis of the erythrocytes with a fixative-free erythrocyte lysis reagent containing ammonium chloride solution (StemCell Technologies), the number of CD34+ and CD34+/KDR+ cells were analyzed in the lymphocyte region. Control stainings with isotype-identical antibodies and unstained samples were performed for each sample. Samples were analyzed for a minimum of 500,000 total events on a Coulter Epics XL flow cytometer (Beckman Coulter) and were analyzed with Cytomics RXP software (Beckman Coulter). The percentage of positive cells was converted into absolute numbers of cells per milliliter by using the white blood cell count, and the percentages of lymphocytes and monocytes were obtained from an automated cell counter (ADVIA 2120; Bayer).


Figure 2
View larger version (20K):
[in this window]
[in a new window]

 
Fig. 2. Gating strategy for group 2 samples. Lymphocytes are gated in a FS/SS plot (A). A second gate is used to include only those cells positive for CD34 with low side scatter (B). CD34+/KDR+ cells are determined in this CD34-expressing population (C).

 
The intraobserver reproducibility was excellent for the two methods, with an intraclass correlation coefficient of 0.97 for method 1 and 0.87 for method 2.

Colony-forming unit assay.   In group 2, PBMC were isolated from 10 ml of peripheral blood and were cultured on fibronectin-coated dishes (BD Biosciences) in Endocult liquid medium (StemCell Technologies) at a density of 5 x 106 PBMC/well. After 2 days in culture, nonadherent cells were harvested and cultured for an additional 3 days at a density of 1 x 106 cells in a fibronectin-coated 24-well culture dish. On day 5 of culture, colonies consisting of a central cluster of round cells and elongating sprouting cells at the periphery were counted manually in a minimum of three wells under an inverted phase-contrast microscope by two independent investigators. Results are expressed as mean colony-forming units (CFU) per well. The intraclass correlation coefficient calculated for the interobserver agreement of CFU count was 0.89), which is evidence of the outstanding agreement between the observers.

Biochemical assays.   In both groups, fasting venous blood was collected in serum tubes for measurement of levels of total cholesterol, HDL, and triglycerides. Samples were immediately centrifuged, and serum was stored at –80°C for later analysis.

Measurement of serum VEGF and NO levels.   Serum NO metabolites and VEGF levels were assessed in group 2 subjects only. Additionally, 15 healthy individuals, aged 20–50 yr, who fulfilled the inclusion criteria were recruited to evaluate potential exercise-induced changes in NO and VEGF levels. Levels of VEGF were measured by high-sensitivity colorimetric sandwich ELISA (Human VEGF Quantikine ELISA kit; R&D Systems) with a lower detection limit of 9 pg/ml. The total NO concentration in serum, prepared by ultrafiltration (14,000 g centrifugation for 30 min using filters with a 10,000 molecular weight cutoff), was measured indirectly by a colorimetric detection of nitrite (NO2) and nitrate (NO3) levels following a nitrate-reduction assay (Total Nitric Oxide and Nitrate/Nitrite Parameter assay kit; R&D Systems) with a lower detection limit of 0.25 µmol/l. This assay determines NO concentrations on the basis of the enzymatic conversion of NO3 to NO2 by nitrate reductase. The reaction is followed by colorimetric detection of NO2 as an azo dye product of the Griess reaction.

Statistics

Analyses were performed in SPSS for Windows version 12.0 (SPSS, Chicago, IL). The normality of continuous data sets was assessed by using one-sample Kolmogorov-Smirnov. Logarithmic transformation was performed where necessary. Continuous data are presented as means ± SD. Paired Student's t-test and Pearson correlation coefficients were applicable. A P value of <0.05 was considered statistically significant.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Demographic, Biochemical, and Exercise Characteristics

Table 1 summarizes the characteristics of the two study groups. Group 1 and group 2 differed only with regards to mean age (23.9 ± 1.4 vs. 36.2 ± 9.3 yr; P = 0.004) and age distribution [22–26 vs. 20–48 yr (min-max)]. The values for body mass index (BMI), blood pressure, and lipoproteins confirmed the low cardiovascular risk profile of the studied subjects. Exercise capacity was excellent, as demonstrated by mean values in excess of 100% of predicted for both VO2peak and maximal workload in the two groups.


View this table:
[in this window]
[in a new window]

 
Table 1. Baseline characteristics of study subjects

 
Number of Circulating EPC

In group 1, the absolute number of circulating CD34+/KDR+ cells increased by 76% following a single exercise bout (15.4 ± 10.7 vs. 27.2 ± 13.7 cells/ml; P = 0.01). A similar change was detected in group 2, with a 69% increase in CD34+/KDR+ cells (30.9 ± 14.6 vs. 52.5 ± 42.6 cells/ml; P = 0.03; Fig. 3A). Despite the significant increase in total white blood cell count induced by exercise (Table 2), the increase in CD34+ cells/ml (39% in group 1; 8% in group 2; Fig. 3B) was smaller than the increase in CD34+/KDR+ cells (76% in group 1; 69% in group 2), suggesting a shift in the total CD34+ pool toward CD34+/KDR+ cells.


Figure 3
View larger version (10K):
[in this window]
[in a new window]

 
Fig. 3. Exercise-induced changes in CD34+/KDR+ cells (A) and CD34+ cells (B). Group 1, n = 11; group 2, n = 14. *P < 0.05; NS not significant.

 

View this table:
[in this window]
[in a new window]

 
Table 2. Numbers of CD34+ cells and CD34+/KDR+ cells before and after exercise

 
Relation of Exercise-Induced Increase in EPC With Cardiovascular Risk Factors

The observed exercise-induced increase in CD34+/KDR+ cells correlated positively with both LDL and total cholesterol/HDL ratio. This finding was consistent in the two study groups (Fig. 4). In group 1, a negative correlation between the increase in CD34+/KDR+ cells and both VO2peak and VO2 at anaerobic threshold was present (Fig. 5). For age, BMI, and systolic and diastolic blood pressure, no significant relations were seen (all P > 0.05; Table 3).


Figure 4
View larger version (16K):
[in this window]
[in a new window]

 
Fig. 4. Correlations of exercise-induced increase in CD34+/KDR+ cells with LDL (A, group 1; C, group 2) and with ratio of total cholesterol to HDL (B, group 1; D, group 2).

 

Figure 5
View larger version (9K):
[in this window]
[in a new window]

 
Fig. 5. Correlations of exercise-induced increase in CD34+/KDR+ cells with oxygen consumption (VO2) at anaerobic threshold (A) and peak oxygen consumption (VO2peak; B).

 

View this table:
[in this window]
[in a new window]

 
Table 3. Relation of exercise-induced increase in endothelial progenitor cells with cardiovascular risk factors

 
CFU Assay

The number of CFU was 11.9 ± 10.9 before and 9.0 ± 8.3 after exercise (P = 0.2). No significant correlations were found between CFU numbers and exercise or biochemical parameters (all P > 0.05).

Serum VEGF and NO Levels

Serum VEGF levels increased with exercise (246.9 ± 142.78 pg/dl before and 262.92 ± 160.0 pg/dl after exercise), with a strong trend toward significance (P = 0.055). There was no relation between the increase in VEGF levels and the increase in circulating CD34+/KDR+ cells, cardiovascular risk factors, or exercise capacity (all P > 0.05).

Serum degradation products of the NO pathway before exercise (47.49 ± 30.85 µmol/l) did not differ from the concentration after exercise (47.85 ± 28.68 µmol/l; P > 0.05).


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The present study was designed to evaluate the effect of a single episode of exercise on the mobilization of CD34+/KDR+ cells in healthy, well-trained individuals with a low cardiovascular risk profile. Several interesting findings emerged from this study.

First, a single maximal exercise bout in healthy subjects elicited a larger increase in CD34+/KDR+ cells than in CD34+ cells, suggesting a shift in circulating CD34+ cells toward CD34+/KDR+ cells. These findings were reproducible in two different cohorts by using two different flow-cytometric techniques. Second, although still within "normal" limits, higher LDL and higher total cholesterol/HDL levels favored the exercise-induced increase in CD34+/KDR+ cells. Third, the observed increase in VEGF levels underscores its possible role as an EPC-mobilizing factor.

Endothelial Integrity and Repair

Impaired endothelial function precedes the development of overt atherosclerosis and has even been observed in otherwise healthy subjects presenting with a limited coronary risk profile (5, 6). The crucial role of endothelial dysfunction has been exemplified in clinical manifestations of atherosclerosis, such as coronary artery disease, peripheral artery disease, and chronic heart failure (18). Healthy endothelium is capable of translating physical and chemical signals and can provide the necessary adjustment to regulate vascular tone, cellular adhesion, and thromboresistance within normal limits. However, prolonged exposure to cardiovascular risk factors exhausts the protective effect of endothelial cells. The preservation of endothelial integrity depends on the balance between injury and the endogenous capacity for repair. Both proliferating mature adjacent endothelial cells and bone marrow-derived EPC are considered key players in endothelial restoration. The latter are released from the bone marrow in response to ischemia or endothelial injury and aim to repair damaged regions, either by producing angiogenic cytokines (17, 25) or by differentiating into endothelial cells (39). The relation between the number and function of circulating EPC and endothelial function has been demonstrated in healthy individuals with a variety of cardiovascular risk factors (15, 37), patients with coronary artery disease (34), PAOD (8), and chronic heart failure (35). Cardioprotective drugs, [i.e., statins (36), angiotensin II receptor antagonists (3), and angiotensin-converting enzyme inhibitors (38)], partly providing benefit through improved endothelial function, have been shown to increase EPC numbers and function.

The Role of Exercise and Physical Training in the Restoration of Endothelial Function

Physical training is a highly effective, multifactorial, nonpharmacological therapeutic approach to treating endothelial dysfunction. Besides its effect on several cardiovascular risk factors, regular exercise is capable of augmenting circulating EPC and of improving their function in different patient populations (16, 22, 29, 31). The underlying mechanism for EPC mobilization is being progressively unraveled. In an animal experiment, Laufs et al. (22) confirmed the central role of NO in the regulation of exercise-induced EPC mobilization. The exercise-induced increase in EPC in eNOS knockout mice was blunted compared with wild-type mice. In addition, the increase in VEGF, seen after physical training, was abolished by cotreatment with NG-nitro-L-arginine methyl ester (L-NAME). In patients with PAOD, 4 wk of daily ischemic exercise training led to a significant increase in circulating EPC, which was linearly correlated with the observed changes in VEGF concentration (29). Conversely, coronary artery disease patients participating in an endurance-training program saw both their EPC numbers and endothelial function improved, in relation to increased NO synthesis, but without VEGF alterations (31).

Reports on the effect of a single exercise bout are scarce, and comparison of scientific data is hampered by the absence of standardized protocols for EPC identification and enumeration. In 25 moderately trained, healthy volunteers, short-term running for 10 min did not augment the number of CD34+/KDR+ cells, whereas intensive and moderate running for 30 min increased CD34+/KDR+ cells significantly (21). In the latter group, CFU numbers were also significantly higher after exercise, without changes in VEGF concentration. In their study including two groups of either young sedentary or trained healthy subjects, Thijssen et al. (33) could not demonstrate an increase in the number of CD34+/KDR+ cells or VEGF concentration immediately after a maximal exercise. Whereas these results clearly contrast with the present data, the baseline absolute number of CD34+/KDR+ in their study population was >10-fold higher, questioning the comparability of either the studied groups or the methods used for flow-cytometric analyses. Circulating EPC, defined as CD133+/vascular endothelial cadherin+ cells, increased fourfold by exercise in middle-aged volunteer subjects characterized by a large variety of cardiovascular risk factors (26). Plasma levels of VEGF and hepatocyte growth factor remained unaltered.

In the present study, we demonstrated that a single maximal exercise bout elicits an increase in CD34+/KDR+ cells and CD34+ cells within just 10 min of exercise. This finding was reproducible in two different populations with the use of two different flow-cytometric techniques. However, the fact that CD34+ increased barely (39% for group 1 and 8% for group 2) compared with CD34+/KDR+ cells (76% for group 1 and 69% for group 2) was remarkable, suggesting a shift in circulating CD34+ cells toward CD34+/KDR+ cells.

Contrary to circulating CD34+/KDR+ EPC, the number of CFU remained unchanged after exercise, and no relation was seen with lipid levels. Although CFU have been related to cardiovascular risk profile and outcome in cardiovascular patients, they have been shown to consist of a mixed population. Recently, evidence was generated that the nature of these cultured cells is different from CD34+/KDR+ EPC per se. They possess myeloid progenitor cell activity, differentiate into phagocytic macrophages, and fail to form vessels in vivo (23, 27, 28, 42).

Despite the fact that real "pathological" tissue ischemia is absent in healthy subjects, pushing themselves to the limits of aerobic capacity during a maximal exercise test will have resulted in a shift to anaerobic glycolytic metabolism, in addition to the generation of oxidative stress. The latter, possibly via increased VEGF levels, might act as a trigger for EPC mobilization. As described by Gavin et al. (10), serum VEGF levels increase directly after exercise and remain elevated for 2 h in healthy subjects. In the present population, the observed increase in VEGF concentration showed a strong trend toward significance. Because there is little data on the time course of serum VEGF regulation following a single bout of exercise, changes in VEGF levels over a larger period of time, particularly in relation to changes in circulating EPC, could provide arguments for a possible paracrine mechanism exerted by EPC and should be studied in future experiments.

Moreover, acute exercise, via higher cardiac output, increases shear stress at the level of the endothelium, which subsequently enhances eNOS activity, resulting in EPC mobilization (1). Despite the strong arguments for the role of eNOS upregulation and NO dependency in mediating exercise training-induced EPC liberation (22), we failed to report an increase in NO bioavailability. Possible explanations include the fact that NO levels are assessed indirectly through NO metabolites and that the assay is limited by various interfering preanalytical (e.g., diet, deproteinization of samples) and analytical factors (e.g., contamination of nitrate in chemicals and laboratory ware). However, direct quantification of NO levels requires electron paramagnetic resonance (EPR) spectroscopy, a technique that is not readily available. Secondly, the effect of acute exercise might be short lived, and interference with NO metabolism could well be a paracrine and local endothelial phenomenon.

There is growing evidence for an inverse relation between resting EPC numbers and cardiovascular risk (40). Inverse relations between atherogenic risk factors and circulating EPC have usually been studied at baseline and in patients at risk for cardiovascular disease. The presented results suggest that in healthy individuals, higher lipid levels, conveying a prooxidant vascular environment, provide a stronger EPC-mobilizing stimulus. Although it seems contradictory at first glance, one could hypothesize that exercise in these individuals, characterized by an endothelium "under stress," might stimulate the generation of reactive oxidant species (ROS), thereby triggering repair mechanisms. ROS production is often evaluated in an indirect manner (12), whereas the optimal technique involves EPR spectroscopy. Future experiments will reveal whether this hypothesis can be confirmed. Of note, Lauer et al. (20) attributed an important eNOS signaling function to exercise-induced endogenous hydrogen peroxide production. In addition, exercise-induced vascular remodeling and enhanced endothelial-dependent vasodilation are limited in time and clearly depend on baseline abnormalities (19). The finding of an inverse relation between maximal and submaximal oxygen consumption and the observed EPC release is concordant with the latter assertion.

Limitations

The present study is limited by the small number of subjects included. However, because there is no consensus nor standard protocol for the quantification of circulating EPC, the fact that our findings were duplicated in a second population using a different flow-cytometric technique is reassuring. A pure methodological comparison of the two techniques, for which a crossover design would have been more appropriate, was beyond the scope of the study.

Secondly, the assessment of changes in EPC function following exercise would have strengthened our message because it has become clear that EPC function is equally important to EPC numbers in vascular homeostasis and angiogenesis (9).

In future studies, it would be interesting to study the time course of EPC mobilization. One could speculate that in the presence of endothelial defects, mobilized EPC are rapidly integrated at sites of injury. Despite the fact that real tissue ischemia is absent in healthy subjects, acute exhaustive exercise might elicit vascular damage and the mobilized EPC might serve to restore vascular integrity.

Conclusions

The present study demonstrates that a single bout of exercise induces a significant shift in circulating CD34+ cells toward CD34+/KDR+ cells in healthy subjects. This response appeared to be larger in subjects with a less favorable lipid profile, which could be a physiological explanation for the well-known benefit of exercise in patients who are prone to develop or already manifest with atherosclerotic disease.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
E. Van Craenenbroeck is supported by a Ph.D. fellowship grant from the Fund for Scientific Research, Flanders, Belgium (FWO-Vlaanderen).


    FOOTNOTES
 

Address for reprint requests and other correspondence: E. Van Craenenbroeck, Dept. of Cardiology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium (e-mail: Emeline.VanCraenenbroeck{at}ua.ac.be)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-tk;1Ihling K, Zeiher AM, Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370–1376, 2003.[CrossRef][Web of Science][Medline]
  2. Arena R, Myers J, Williams MA, Gulati M, Kligfield P, Balady GJ, Collins E, Fletcher G. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation 116: 329–343, 2007.[Free Full Text]
  3. Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, Fliser D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 45: 526–529, 2005.[Abstract/Free Full Text]
  4. Belardinelli R, Georgiou D, Cianci G, Berman N, Ginzton L, Purcaro A. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and prognostic implications. Circulation 91: 2775–2784, 1995.[Abstract/Free Full Text]
  5. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111–1115, 1992.[CrossRef][Web of Science][Medline]
  6. Clarkson P, Montgomery HE, Mullen MJ, Donald AE, Powe AJ, Bull T, Jubb M, World M, Deanfield JE. Exercise training enhances endothelial function in young men. J Am Coll Cardiol 33: 1379–1385, 1999.[Abstract/Free Full Text]
  7. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 115: 1285–1295, 2007.[Free Full Text]
  8. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, Grego F, Vigili de Kreutzenberg S, Tiengo A, Agostini C, Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 26: 2140–2146, 2006.[Abstract/Free Full Text]
  9. Galasso G, Schiekofer S, Sato K, Shibata R, Handy DE, Ouchi N, Leopold JA, Loscalzo J, Walsh K. Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res 98: 254–261, 2006.[Abstract/Free Full Text]
  10. Gavin TP, Robinson CB, Yeager RC, England JA, Nifong LW, Hickner RC. Angiogenic growth factor response to acute systemic exercise in human skeletal muscle. J Appl Physiol 96: 19–24, 2004.[Abstract/Free Full Text]
  11. Goon PK, Boos CJ, Stonelake PS, Blann AD, Lip GY. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison. Thromb Haemost 96: 45–52, 2006.[Web of Science][Medline]
  12. Goto C, Nishioka K, Umemura T, Jitsuiki D, Sakagutchi A, Kawamura M, Chayama K, Yoshizumi M, Higashi Y. Acute moderate-intensity exercise induces vasodilation through an increase in nitric oxide bioavailiability in humans. Am J Hypertens 20: 825–830, 2007.[CrossRef][Web of Science][Medline]
  13. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R, Yu J, Adams V, Niebauer J, Schuler G. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98: 2709–2715, 1998.[Abstract/Free Full Text]
  14. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 45: 1441–1448, 2005.[Abstract/Free Full Text]
  15. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593–600, 2003.[Abstract/Free Full Text]
  16. Hoetzer GL, Van Guilder GP, Irmiger H, Keith RS, Stauffer BL, DeSouza CA. Aging, exercise and endothelial progenitor cell clonogenic and migratory capacity in men. J Appl Physiol 102: 847–852, 2006.[CrossRef][Web of Science][Medline]
  17. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24: 288–293, 2004.[Abstract/Free Full Text]
  18. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19: 918–925, 1992.[Abstract]
  19. Kojda G, Hambrecht R. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67: 187–197, 2005.[Abstract/Free Full Text]
  20. Lauer N, Suvorava T, Rüther U, Jacob R, Meyer W, Harrison D, Kojda G. Critical involvement of hydrogen peroxide in exercise-induced up-regulation of endothelial NO synthase. Cardiovasc Res 65: 254–262, 2005.[Abstract/Free Full Text]
  21. Laufs U, Urhausen A, Werner N, Scharhag J, Heitz A, Kissner G, Bohm M, Kindermann W, Nickenig G. Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur J Cardiovasc Prev Rehabil 12: 407–414, 2005.[CrossRef][Web of Science][Medline]
  22. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche E, Bohm M, Nickenig G. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109: 220–226, 2004.[Abstract/Free Full Text]
  23. Lopez-Holgado N, Alberca M, Sanchez-Guijo F, Villaron E, Almeida J, Martin A, Armellini A, Garcia C, Blanco B, Sanchez-Abarca I, Martin S, Perez-Simon JA, Garcia-Sanz R, San Miguel JF, del Canizo MC. Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers. Cytotherapy 9: 14–22, 2007.[Medline]
  24. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346: 793–801, 2002.[Abstract/Free Full Text]
  25. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164–1169, 2003.[Abstract/Free Full Text]
  26. Rehman J, Li J, Parvathaneni L, Karlsson G, Panchal VR, Temm CJ, Mahenthiran J, March KL. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 43: 2314–2318, 2004.[Abstract/Free Full Text]
  27. Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, Guelly C, Strunk D. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells 25: 1746–1752, 2007.[CrossRef][Web of Science][Medline]
  28. Rohde E, Malischnik C, Thaler D, Maierhofer T, Linkesch W, Lanzer G, Guelly C, Strunk D. Blood monocytes mimic endothelial progenitor cells. Stem Cells 24: 357–367, 2006.[CrossRef][Web of Science][Medline]
  29. Sandri M, Adams V, Gielen S, Linke A, Lenk K, Krankel N, Lenz D, Erbs S, Scheinert D, Mohr FW, Schuler G, Hambrecht R. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 111: 3391–3399, 2005.[Abstract/Free Full Text]
  30. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111: 2981–2987, 2005.[Abstract/Free Full Text]
  31. Steiner S, Niessner A, Ziegler S, Richter B, Seidinger D, Pleiner J, Penka M, Wolzt M, Huber K, Wojta J, Minar E, Kopp CW. Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis 181: 305–310, 2005.[CrossRef][Web of Science][Medline]
  32. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 347: 1941–1951, 2002.[Free Full Text]
  33. Thijssen DH, Vos JB, Verseyden C, van Zonneveld AJ, Smits P, Sweep FC, Hopman MT, de Boer HC. Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training. Aging Cell 5: 495–503, 2006.[CrossRef][Web of Science][Medline]
  34. Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, Poole-Wilson PA, Ertl G, Bauersachs J. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 46: 1693–1701, 2005.[Abstract/Free Full Text]
  35. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110: 1209–1212, 2004.[Abstract/Free Full Text]
  36. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885–2890, 2001.[Abstract/Free Full Text]
  37. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1–E7, 2001.[Web of Science][Medline]
  38. Wang CH, Verma S, Hsieh IC, Chen YJ, Kuo LT, Yang NI, Wang SY, Wu MY, Hsu CM, Cheng CW, Cherng WJ. Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. J Mol Cell Cardiol 41: 34–43, 2006.[CrossRef][Medline]
  39. Wassmann S, Werner N, Czech T, Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 99: e74–e83, 2006.[CrossRef][Web of Science][Medline]
  40. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999–1007, 2005.[Abstract/Free Full Text]
  41. Werner N, Wassmann S, Ahlers P, Schiegl T, Kosiol S, Link A, Walenta K, Nickenig G. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 102: 565–571, 2007.[CrossRef][Web of Science][Medline]
  42. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA. Re-defining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: 1801–1809, 2006.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. T. Jenkins, S. Witkowski, E. E. Spangenburg, and J. M. Hagberg
Effects of acute and chronic endurance exercise on intracellular nitric oxide in putative endothelial progenitor cells: role of NAPDH oxidase
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1798 - H1805.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
104/4/1006    most recent
01210.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Craenenbroeck, E. M. F.
Right arrow Articles by Conraads, V. M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Craenenbroeck, E. M. F.
Right arrow Articles by Conraads, V. M. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.